Life Insurance With Lymphoma in Canada

Two people with the same lymphoma can walk away with very different offers. Hodgkin and non-Hodgkin lymphoma are not underwritten the same way, and the time since your last treatment moves a file more than almost anything else on it.

This guide walks through how Canadian insurers actually read a lymphoma history, when you are likely to qualify, and the steps that protect your application before you ever submit it.

Hodgkin vs Non-Hodgkin: Why Your Lymphoma Type Decides the Path

The single biggest thing that changes is how the insurer files your case, because Hodgkin and non-Hodgkin lymphoma are not the same risk, even when a carrier lists them under one “lymphoma” heading.

Here is what bugs me about the way some carriers handle this. They bucket Hodgkin lymphoma right in with non-Hodgkin, and the two are not the same animal. One is often considered highly curable. The other is really a whole family of conditions that behave very differently, the way leukemia gets read on its own terms rather than as one thing.

Why does that matter to you? Because if your file gets read against the more cautious assumptions, a highly curable Hodgkin history can get priced closer to something it is not. The fix is rarely arguing the medicine. It is putting your file in front of an insurer that reads your specific type the way it should be read.

Directions are illustrative, based on current underwriting guidance and broker experience, and vary by insurer. Every offer is subject to full underwriting.

Carriers do not even agree on how to sort the two. As you will see below, one insurer groups Hodgkin and non-Hodgkin under a single stage grid, while another splits them and treats them on separate timelines. That is exactly why the insurer you apply to matters more than the label on your diagnosis. Knowing which one leans your way, before you apply, is most of the job.

How Canadian Insurers Actually Rate Lymphoma

There are two separate tracks, and it helps to know which one you are on. Fully underwritten carriers rate lymphoma on a stage-and-time grid, where your stage at diagnosis and years since treatment shape the outcome. No-medical options work differently and do not use these grids at all, which matters a lot if the fully underwritten route wants you to wait.

Start with the fully underwritten track. A quick note on the language first. A flat extra is a temporary add-on, usually quoted per $1,000 of coverage per year, that falls off after a set number of years. A percentage rating is an ongoing increase over the standard price that does not expire on its own. And postponed is not declined: it means the timing is not right yet, not that the door is shut for good.

Illustrative, based on current carrier underwriting guidance and subject to change. Confirm your own file with a licensed broker.

Empire Life takes the opposite approach and splits the two types, which is the divergence worth knowing. For Hodgkin lymphoma, they generally postpone for at least a year after treatment, then can look at a flat extra of roughly $8 to $16 per $1,000 for about five years, sometimes with a percentage rating added. For non-Hodgkin lymphoma, they usually want at least three years clear, after which outcomes can range from a percentage rating in the area of 200% down to a decline, depending on the subtype. Same person, same calendar, different door depending on the type and the carrier.

Here is the practical read. A flat extra is often the friendlier outcome, because it is temporary and comes off on schedule. A percentage rating is different: it stays in place unless you later ask the insurer to reconsider or apply for new coverage, and any improvement is subject to fresh evidence and approval. Either way, a rated offer is still an offer, and in my experience getting coverage locked in beats waiting and hoping.

When You Can Apply, and What Underwriters Ask For

Timing is the lever you actually control, and on the fully underwritten track more time in remission almost always improves the read. A clean, treatment-free follow-up stretch is the strongest signal an underwriter has that the risk has settled.

Rough windows look like this, though every carrier draws its own lines and any of these can shift with subtype, stage or relapse history:

When you do apply on the fully underwritten track, the insurer builds its picture from your medical records, not just the application form. Evidence may include an exam, bloodwork, medical records, or other reports, and for a cancer history they will usually request an Attending Physician Statement, which is the file from your own doctors and specialists.

For a lymphoma history, expect them to want:

• the pathology report confirming your subtype
• staging documentation from diagnosis
• a treatment summary with start and completion dates
• oncology follow-up notes
• recent surveillance imaging or bloodwork
• and often a fresh lab panel the insurer orders itself

The single most useful thing you can do is have this ready before you start. Follow-ups that stall waiting on a doctor’s office are the most common reason a straightforward file drags. If you want the full picture of how underwriting decisions get made, our overview of life insurance for cancer in Canada walks through it.

Your Policy Options With a Lymphoma History

You have more than the two extremes most articles describe, and the middle option is the one that gets missed. The honest map runs from fully underwritten at one end to guaranteed issue at the other, with no-medical coverage in between, and no-medical is not a single thing.

Think of it as three doors, not two:

The current version of this page implied guaranteed issue was the fallback for anyone recently diagnosed. That understates what is available. For a lot of lymphoma survivors, no-medical coverage at a meaningful amount is the practical answer while the fully underwritten clock keeps running.

How to Test Your Options Before You Apply

You can find out where you would likely land before you ever put your name on a formal application. I do a preliminary inquiry, no confidential information, just the generic clinical picture, and the insurer’s underwriting desk comes back with a tentative direction.

That matters more than it sounds. A formal application creates an underwriting record, and future applications commonly ask whether you have ever been rated, postponed or declined. Underwriting-significant information can also be shared through an industry database that participating insurers use. It is not the case that every insurer automatically sees every past decision, but you can see why I would rather read the likely answer first than fire off applications and hope.

This is also why the word on the letter matters. A postponement is not a decline. It means the timing is not right yet, come back when you have more clear time behind you, not that coverage is off the table. I have had plenty of postponed files come back approved once the clock caught up.

What Life Insurance Costs After Lymphoma

Your result after lymphoma can fall into several categories, so there is no single number. Depending on the subtype, stage, treatment, recurrence history and time since treatment, an insurer may offer standard pricing, a temporary flat extra, an ongoing percentage rating, a postponement, or no fully underwritten offer at all. Temporary extras may fall away on schedule, while a percentage rating generally remains unless the insurer later approves a reconsideration or new coverage is issued.

It helps to start with the standard baseline, because a flat extra gets added on top of it. These are illustrative starting-from figures for a healthy applicant on a 10-year term, standard rates, non-smoker, monthly:

Sample premiums are for illustration only and assume non-smoker status, standard underwriting, no additional health concerns, and current carrier rates in Ontario at the time of quoting. Final premiums depend on age, sex, province, coverage amount, term length, health history and insurer approval.

Now the lymphoma piece. If your file draws a flat extra, that add-on is calculated per $1,000 of coverage and applies for a set number of years. A temporary flat extra normally ends according to its original schedule. A percentage rating does not, so it is worth knowing which type of additional premium the insurer is offering, because lowering a percentage rating means asking the insurer to reconsider or applying for fresh coverage, with the outcome subject to current evidence and approval.

Two habits genuinely help the long-run cost. Applying once you have more clear time behind you tends to shrink or remove a flat extra, and paying annually may reduce the total premium compared with monthly, although the difference varies by insurer and product. For the wider picture on what drives premiums, see our guide to how much life insurance costs in Canada.

Family History and the Genetic Non-Discrimination Act

A family history of lymphoma will not, on its own, disqualify you, and Canada gives you a specific protection here that most people do not know they have. Under the federal Genetic Non-Discrimination Act, an insurer cannot require you to take a genetic test or hand over the results of one you have already taken as a condition of coverage.

So if you are worried that a relative’s diagnosis will be held against you, the honest answer is that family history can be one factor an underwriter considers, but your own record does the heavy lifting. A predictive genetic test you may have taken is off the table for them, by law.

Common Questions

What a Settled Lymphoma File Can Look Like

One pattern I see often enough to share: a Hodgkin lymphoma survivor roughly a decade past treatment, chemotherapy only, no surgery or hospital stays, no ongoing oncologist, just routine bloodwork through a family doctor, ended up with better pricing than a policy they had bought a few years earlier.

The takeaway is not that everyone gets a great rate. Relapse, a transplant, ongoing complications, or a higher-risk non-Hodgkin subtype can all keep the weight on a file longer. But for many survivors, the underwriting weight of a lymphoma history eases as stable, treatment-free time passes, which is exactly why timing and carrier choice do most of the work.